INSIGHTS ON DRUG DEVELOPMENT

• Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis

  Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

• Enable Low Volume Delivery Of Proteins In Aqueous Solutions

  Achieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.

• Asymchem's World-Class TIDES Hub: Scaling Innovations For The Future

  A tech‑driven, integrated ecosystem strengthens TIDES development and scale‑up, enabling reliable progression from early molecular design to commercial delivery as pipelines grow more complex.

• ddPCR Workflows For Gene Expression Analysis

  RT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Learn how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies.

• Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development

  1/15/2026

  Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.

• Why Reshoring Is An Essential Strategy For ADC Supply Chain Security

  2/24/2026

  Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.

• Innovative Strategies For Residual DNA And Viral Titre Quantitation

  5/22/2025

  Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.

• Support For Your Production Challenges

  7/15/2024

  Ensure your manufacturing operations run smoothly and efficiently by collaborating with experts to tackle production, processing, or quality control issues.

• Overcoming Challenges To High-Concentration Formulation Development

  3/25/2025

  Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.